Prevalence of various types of cancer, coupled with rising need for advanced cancer treatment and drugs are key factors driving market revenue growth.
Market Size - USD 9,143.1 Million in 2020, Market Growth - CAGR of 18.8%, Market Trends - Increasing research and development to explore novel treatment for cancer.
The global epigenetic market size is expected to reach USD 36.52 Billion in 2028, and register a CAGR of 18.8% during the forecast period. Rising number of deaths by cancer, global geriatric population globally, and rising awareness regarding need for epigenetic are factors expected to drive market growth. According to a report by World Health Organization, number of cancer patients is going to increase to 19.3 Million by 2025 globally.
High cost of instruments required for epigenetics research and maintenance are factors that could hamper market growth to some extent.
Some Key Findings From the Report:
.
For the purpose of this report, the global epigenetics market is segmented on the basis of product, technology, application, end use, and region:
Product Outlook
Technology Outlook
Application Outlook
End Use Outlook
Region Outlook
Reasons to Buy the Report
Market Size - USD 9,143.1 Million in 2020, Market Growth - CAGR of 18.8%, Market Trends - Increasing research and development to explore novel treatment for cancer.
The global epigenetic market size is expected to reach USD 36.52 Billion in 2028, and register a CAGR of 18.8% during the forecast period. Rising number of deaths by cancer, global geriatric population globally, and rising awareness regarding need for epigenetic are factors expected to drive market growth. According to a report by World Health Organization, number of cancer patients is going to increase to 19.3 Million by 2025 globally.
High cost of instruments required for epigenetics research and maintenance are factors that could hamper market growth to some extent.
Some Key Findings From the Report:
- Among the product segments, the reagents segment accounted for major revenue share in 2020. The kits segment is expected to register the highest revenue growth rate during the forecast period. Ready-to-use kits are in high demand for detection of epigenetic modifications.
- Among the technology segments, the DNA methylation segment accounted for the largest revenue share of 36.3% in 2020. The histone acetylation segment is expected to register the highest revenue growth rate during the forecast period, owing to its enhanced efficacy due to development of novel mechanisms.
- Among the application segments, the oncology segment accounted for the largest revenue share in the global epigenetics market in 2020. Rising number of cancer patients globally and increasing research and development for offering novel drugs and treatment is supporting revenue growth of this segment.
- North America market accounted for the largest revenue share in the global epigenetics market in 2020, due to increasing initiative by governments in countries in the region to encourage research on epigenetics and strong presence of major players in the region
.
- The Asia Pacific market size was USD 2,011.5 Million in 2020, due to increasing medical tourism and rapidly increasing investments for research and development in the field.
- Some of the prominent players in the market include Illumina, Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Bio-Rad Laboratories, New England Biolabs, Agilent, QIAGEN, Zymo Research, PerkinElmer, and Diagenode. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global epigenetics market is segmented on the basis of product, technology, application, end use, and region:
Product Outlook
- Reagents
- Kits
- Chip sequencing kit
- Whole Genomic Amplification kit
- Bisulfite Conversion kit
- RNA sequencing kit
- Others
- Instruments
- Enzymes
- Services
Technology Outlook
- DNA Methylation
- Histone Methylation
- Histone Acetylation
- Large non - coding RNA
- MicroRNA modification
- Chromatin structures
Application Outlook
- Oncology
- Solid tumors
- Liquid tumors
- Non - oncology
- Inflammatory diseases
- Metabolic diseases
- Infectious diseases
- Cardiovascular diseases
- Others
End Use Outlook
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
Region Outlook
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Epigenetics Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of all the major players in the Epigenetics Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Table of Contents
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Epigenetics Segmentation & Impact Analysis
Chapter 5. Epigenetics Market By Product Type Insights & Trends
Chapter 6. Epigenetics Market By Technology Insights & Trends
Chapter 7. Epigenetics Market By Application Insights & Trends
Chapter 8. Epigenetics Market By End-Use Insights & Trends
Chapter 9. Epigenetics Market Regional Outlook
Chapter 10. Competitive Landscape
Chapter 11. Company Profiles
Companies Mentioned
- Illumina (U.S.)
- Thermo Fisher Scientific (U.S.)
- Merck Millipore (U.S.)
- Abcam (U.K.)
- Active Motif (U.S.)
- Bio-Rad Laboratories (U.S.)
- New England Biolabs (U.S.)
- Agilent (U.S.)
- QIAGEN (Netherlands)
- Zymo Research (U.S.)
- PerkinElmer (U.S.)
- Diagenode (Belgium).